Multiple Testing in Group Sequential Clinical Trials
|
|
- Peregrine Cunningham
- 6 years ago
- Views:
Transcription
1 Multiple Testing in Group Sequential Clinical Trials Tian Zhao Supervisor: Michael Baron Department of Mathematical Sciences University of Texas at Dallas 7/2/213
2 1 Sequential statistics Problem 2 Bonferroni approach 3 Truncated Sequential Probability Ratio Test 4
3 Sequential statistics Sequential statistics Problem Multiple testing in clinical trials Multiple endpoints ( efficacy and safety ) Multiple treatment arms or doses of a drug Overall, get an answer to several questions
4 Sequential statistics Sequential statistics Problem Multiple testing in clinical trials Multiple endpoints ( efficacy and safety ) Multiple treatment arms or doses of a drug Overall, get an answer to several questions Sequential / group sequential clinical trials Interim analysis (Flector trial: stop for futility) Sequential clinical trials always have a restriction on the maximum number of sampled groups (K)
5 Our problem Sequential statistics Problem Test multiple hypotheses based on sequentially observed data, achieving a decision on each individual test Group sequential sampling
6 Our problem Sequential statistics Problem Test multiple hypotheses based on sequentially observed data, achieving a decision on each individual test Group sequential sampling Formulation
7 Our problem Sequential statistics Problem Test multiple hypotheses based on sequentially observed data, achieving a decision on each individual test Group sequential sampling Formulation Goal
8 Group sequential methods Sequential statistics Problem Group sequential sampling A number of group sequential procedures have been proposed for testing ONE hypothesis. Pocock (1977) applies repeated significance tests to group sequential trials with equal-size groups and derives a constant critical value on the standardized normal Z scale across all stages that control Type I error. O Brien and Fleming (1979) propose a sequential procedure that has boundary values decrease over the stages on the standardized normal Z scale
9 Formulation Sequential statistics Problem Observe a sequence of iid random vectors X n, n = 1, 2,... X n = (X (1) 1,...X n (d) ) R d is a set of measurements on unit n. X (j) i f j (x θ (j) ) Multiple hypotheses Test d hypotheses: H (j) : θ (j) = θ (j) vs H (j) A : θ(j) = θ (j) 1, for j = 1, 2,..., d Let m = constant be the group size and T be a stopping time Tests are based on a group sequential experiment. Data are collected in groups of m patients.
10 Goal Sequential statistics Problem Control Familywise Type I error rate = FWER-I = P( At least one Type I error ) α Familywise Type II error rate = FWER-II = P( At least one Type II error) β P(T K) = 1, T is stopping time, K = given integer = max allowed number of groups Do it at low expected cost
11 Bonferroni approach Bonferroni approach Bonferroni approach : control of both error rates. Choose α j (, 1), αj = α; β j (, 1), βj = β Test H (j) at level α j and power (1 β j ) by any known sequential procedure d P j=1 d P j=1 Type I error on H (j) Type II error on H (j) A ( P = α j = α ( P = β j = β Type I error on H (j) Type II error on H (j) A ) )
12 of Bonferroni Methods Bonferroni inequality is very crude for moderate to large d, extend to Holm s stepwise approach. Order the log-likelihood ratio (LLR) statistics in decreasing (step-down)/increasing (step-up) Choose stopping boundaries for the ordered LLR Define the stopping rule and decision rules This requires analysis of the group sequential test Boundaries of Pocock, O Brien-Fleming, Wang-Tsiatis tests are computed numerically, not tractable to analyze Derive equations for Whitehead triangular test and Truncated SPRT
13 Group sequential tests Z k Pocock test Z k O Brien-Fleming test k k Z k Whitehead test k Λ k Truncated SPRT k
14 Derive Truncated SPRT SPRT Choose stopping boundaries a, b to control α and β where, a = 1 β α b = β 1 α SPRT control both α, β among all sequential tests that have P(Type I error) α P(Type II error) β
15 Wald s SPRT a Λ k R e j e c t H k T b A c c e p t H
16 Truncated SPRT Stopping time and Decision rule Following SPRT approach for single hypothesis testing, truncated SPRT is based on log-likelihood rations Stopping time Λ n = ln f (x θ 1) f (x θ ) T = min(k, min {n : Λ n / (b, a)}) K Decision rule, { reject H if Λ δ = T a or Λ T c T = K accept H if Λ T b or Λ T < c T = K
17 Truncated SPRT (cont d) a c b Λ k R e j e c t H K A c c e p t H A c c e p t H Reject H k
18 Truncated SPRT (cont d) Plan Evaluate performance of TSPRT, probabilities of Type I and Type II errors. Find equations of the stopping boundaries and the required group size to control P{Type I error} and P{Type II error}. Then develop Holm-type stepwise sequential procedures to test d hypotheses controlling familywise error rates I and II.
19 Truncated SPRT. Performance evaluation. a c b Evaluate probabilities of Type I and Type II errors by comparison between TSPRT and SPPRT. Λ k Both tests reject H R e j e c t H k K A c c e p t H
20 Truncated SPRT. Performance evaluation. a c b Λ k R e j e c t H TSPRT rejects H but SPRT accepts it k K A c c e p t H
21 Truncated SPRT. Performance evaluation. a Λ k R e j e c t H Both tests accept H c b k K A c c e p t H
22 Truncated SPRT. Performance evaluation. a c b Λ k TSPRT accepts H R e j e c t H but SPRT rejects it k A c c e p t H K
23 Probability of Type I Error Choose c to attain P(Type I error TSPRT ) α. Let Λ K = Km j=1 ln f (x j θ 1 ) f (x j θ ). For a given α 1=level for SPRT, P(Type I error TSPRT ) = P H (Type I error SPRT ) +P H ({Λ 1,...Λ K 1 (b, a)} {Λ K [c, a)} {Λ n b before Λ n a}) P H ({Λ 1,...Λ K 1 (b, a)} {Λ K (b, c)} {Λ n a before Λ n b}) α 1 + P(A) P(B) We need to make P(A) α α 1
24 Type I error P(A) P H (Λ K [c, a))p H (Λ n b before Λ n a Λ K c) P H (Λ K c)p H (Λ n b before Λ n a Λ K c) P H (Λ K c)p H (Λ n b before Λ n a Λ K = c)
25 Truncated SPRT (cont d) Derivations Assumption: ( General ) Exponential family Test H : θ = θ vs H A : θ = θ 1. Exponential family is written in the canonical form with η = canonical parameter as follows, f (x η) = f (x )e ηx ψ(η) where, ψ() = and µ(η) = EX = ψ (η), VarX = ψ (η)
26 Truncated SPRT (cont d) Chernoff Inequality In general case, we have P( n i=1 Z j ny) e n sup t {ty ψz (t)} here, Z = ln f (x θ 1) f (x θ ), c = ny
27 Truncated SPRT (cont d) Normal as example Observe X 1, X 2,..., X n N(θ, σ 2 ), we can write it as f (x θ, σ 2 ) = 1 2πσ e x2 2σ 2 e θx σ 2 θ2 2σ 2 here, η = θ σ 2, f (x ) = 1 2πσ e x2 2σ 2, ψ x (η) = σ2 η 2 2
28 Truncated SPRT (cont d) Normal as example By Chernoff Inequality, Therefore, sup{ty ψ z (t)} attained at ˆt = [ψ z] 1 (y) t P( n Z j ny) e n{ i=1 σ 2 y 2 2(θ 1 θ ) y+ (θ 1 θ )2 8σ 2 }
29 Type I error P(A) P H (Λ K [c, a))p H (Λ n b before Λ n a Λ K c) Hence, we have P H (Λ K c)p H (Λ n b before Λ n a Λ K c) P H (Λ K c)p H (Λ n b before Λ n a Λ K = c) P(A) 1 α 1e c 1 α 1 β e n{ σ 2 c 2 2n 2 (θ 1 θ ) 2 + c 2n + (θ 1 θ )2 8σ 2 } α α1
30 Type II error For α 1 =level for SPRT (, α), β 1 = power for SPRT (, β) Let a = ln α 1, and b = ln β 1 Choose c 1 to control Type I error: 1 α 1 e c 1 e n{ 1 α 1 β 1 σ 2 c 2 1 2n 2 (θ 1 θ ) 2 + c 1 2n + (θ 1 θ )2 8σ 2 } α α1 Choose c 2 to control Type II error: 1 β 1 e c 2 e n{ 1 α 1 β 1 σ 2 c 2 2 2n 2 (θ 1 θ ) 2 c 2 2n + (θ 1 θ )2 8σ 2 } β β1
31 Type II error Therefore, if θ 1 θ σ c 1 >, we have, ( ) 2 n ln (α α 1)(1 α 1 β 1 ) (θ 1 θ ) n(θ 1 θ ) 2σ σ ( ) 2 c 2 n ln (β β 1)(1 α 1 β 1 ) + (θ 1 θ ) 2σ Minimize n to control both Type I error and Type II error n(θ 1 θ ) σ ( 2σ 2 ln (α α1 )(1 α 1 β 1 ) + ln (β β 1 )(1 α 1 β 1 ) n = (θ 1 θ ) 2 ) 2
32 Stepwise method for Truncated SPRT Test d hypotheses: H (j) : θ (j) = θ (j) vs H (j) A : θ(j) = θ (j) 1 j = 1, 2,..., d Test statistics Λ (j) k = ln f j (X (j) i θ (j) 1 ) f j (X (j) i θ (j) ) Order test statistics Λ [1] k... Λ [d] k, let H(j) be the corresponding tested null hypotheses arranged in the same order. a j = ln α α 1 d j+1, b j = ln β β 1 j
33 Stepwise method for Truncated SPRT(cont d) Decision rule (reject one by one, accept all) If Λ [1] k b 1 stop, accept H [1],..., H[d] If Λ [1] k a 1 reject H [1], go to H[2] If Λ [1] k (b 1, a 1 ), continue sampling...
34 Stepwise method for Truncated SPRT(cont d) At k = K, If Λ [j] K / (b j, a j ), stop If Λ [j] K (b j, a j ), Λ [j] K > c j stop, reject Λ [j] K < c j stop, accept This stepwise method can control FWER-I and FWER-II
35 Pocock Test Pocock derives the constant boundary [ C p, C p ] on the standardized Z scale, if Z / [ C p, C p ], stop and reject H, otherwise, keep sampling, after K groups, if Z / [ C p, C p ], stop and reject H, otherwise, stop and accept H Fallback method for Pocock: recycle β j on all H (j) that were rejected, then at k = K, test remaining H (j) at higher β j β j (1) β j (K) = 1 i:h (i) was rejected β i Testing with higher β means that we can accept more often, expand the acceptance region. P(reject H ) reduces, we can shrink boundary [ C p, C p ] to meet the α level, and then reduce m.
36 Use stepwise approach to multiple hypotheses starting from various standard group sequential methods Thank you!
37 Use stepwise approach to multiple hypotheses starting from various standard group sequential methods Evaluate performance of fallback procedures, compare fallback and stepwise testing approaches Thank you!
38 Use stepwise approach to multiple hypotheses starting from various standard group sequential methods Evaluate performance of fallback procedures, compare fallback and stepwise testing approaches Composite hypotheses and nuisance parameters. Sequential t-test. Thank you!
39 Use stepwise approach to multiple hypotheses starting from various standard group sequential methods Evaluate performance of fallback procedures, compare fallback and stepwise testing approaches Composite hypotheses and nuisance parameters. Sequential t-test. Examples of clinical data Thank you!
Testing a secondary endpoint after a group sequential test. Chris Jennison. 9th Annual Adaptive Designs in Clinical Trials
Testing a secondary endpoint after a group sequential test Christopher Jennison Department of Mathematical Sciences, University of Bath, UK http://people.bath.ac.uk/mascj 9th Annual Adaptive Designs in
More informationType I error rate control in adaptive designs for confirmatory clinical trials with treatment selection at interim
Type I error rate control in adaptive designs for confirmatory clinical trials with treatment selection at interim Frank Bretz Statistical Methodology, Novartis Joint work with Martin Posch (Medical University
More informationThe Design of Group Sequential Clinical Trials that Test Multiple Endpoints
The Design of Group Sequential Clinical Trials that Test Multiple Endpoints Christopher Jennison Department of Mathematical Sciences, University of Bath, UK http://people.bath.ac.uk/mascj Bruce Turnbull
More informationSuperchain Procedures in Clinical Trials. George Kordzakhia FDA, CDER, Office of Biostatistics Alex Dmitrienko Quintiles Innovation
August 01, 2012 Disclaimer: This presentation reflects the views of the author and should not be construed to represent the views or policies of the U.S. Food and Drug Administration Introduction We describe
More informationPower assessment in group sequential design with multiple biomarker subgroups for multiplicity problem
Power assessment in group sequential design with multiple biomarker subgroups for multiplicity problem Lei Yang, Ph.D. Statistical Scientist, Roche (China) Holding Ltd. Aug 30 th 2018, Shanghai Jiao Tong
More informationInterim Monitoring of Clinical Trials: Decision Theory, Dynamic Programming. and Optimal Stopping
Interim Monitoring of Clinical Trials: Decision Theory, Dynamic Programming and Optimal Stopping Christopher Jennison Department of Mathematical Sciences, University of Bath, UK http://people.bath.ac.uk/mascj
More informationCHL 5225H Advanced Statistical Methods for Clinical Trials: Multiplicity
CHL 5225H Advanced Statistical Methods for Clinical Trials: Multiplicity Prof. Kevin E. Thorpe Dept. of Public Health Sciences University of Toronto Objectives 1. Be able to distinguish among the various
More informationGroup sequential designs for Clinical Trials with multiple treatment arms
Group sequential designs for Clinical Trials with multiple treatment arms Susanne Urach, Martin Posch Cologne, June 26, 2015 This project has received funding from the European Union s Seventh Framework
More informationSequential Bonferroni Methods for Multiple Hypothesis Testing with Strong Control of Familywise Error Rates I and II
Sequential Bonferroni Methods for Multiple Hypothesis Testing with Strong Control of Familywise Error Rates I and II Shyamal K. De and Michael Baron Department of Mathematical Sciences, The University
More informationOptimising Group Sequential Designs. Decision Theory, Dynamic Programming. and Optimal Stopping
: Decision Theory, Dynamic Programming and Optimal Stopping Christopher Jennison Department of Mathematical Sciences, University of Bath, UK http://people.bath.ac.uk/mascj InSPiRe Conference on Methodology
More informationGroup Sequential Trial with a Biomarker Subpopulation
Group Sequential Trial with a Biomarker Subpopulation Ting-Yu (Jeff) Chen, Jing Zhao, Linda Sun and Keaven Anderson ASA Biopharm Workshop, Sep 13th. 2018 1 Outline Motivation: Phase III PD-L1/PD-1 Monotherapy
More informationPubh 8482: Sequential Analysis
Pubh 8482: Sequential Analysis Joseph S. Koopmeiners Division of Biostatistics University of Minnesota Week 8 P-values When reporting results, we usually report p-values in place of reporting whether or
More informationControl of Directional Errors in Fixed Sequence Multiple Testing
Control of Directional Errors in Fixed Sequence Multiple Testing Anjana Grandhi Department of Mathematical Sciences New Jersey Institute of Technology Newark, NJ 07102-1982 Wenge Guo Department of Mathematical
More informationGroup Sequential Tests for Delayed Responses. Christopher Jennison. Lisa Hampson. Workshop on Special Topics on Sequential Methodology
Group Sequential Tests for Delayed Responses Christopher Jennison Department of Mathematical Sciences, University of Bath, UK http://people.bath.ac.uk/mascj Lisa Hampson Department of Mathematics and Statistics,
More informationAdaptive, graph based multiple testing procedures and a uniform improvement of Bonferroni type tests.
1/35 Adaptive, graph based multiple testing procedures and a uniform improvement of Bonferroni type tests. Martin Posch Center for Medical Statistics, Informatics and Intelligent Systems Medical University
More informationMonitoring clinical trial outcomes with delayed response: incorporating pipeline data in group sequential designs. Christopher Jennison
Monitoring clinical trial outcomes with delayed response: incorporating pipeline data in group sequential designs Christopher Jennison Department of Mathematical Sciences, University of Bath http://people.bath.ac.uk/mascj
More informationThe Design of a Survival Study
The Design of a Survival Study The design of survival studies are usually based on the logrank test, and sometimes assumes the exponential distribution. As in standard designs, the power depends on The
More informationA Brief Introduction to Intersection-Union Tests. Jimmy Akira Doi. North Carolina State University Department of Statistics
Introduction A Brief Introduction to Intersection-Union Tests Often, the quality of a product is determined by several parameters. The product is determined to be acceptable if each of the parameters meets
More informationSequential tests controlling generalized familywise error rates
Sequential tests controlling generalized familywise error rates Shyamal K. De a, Michael Baron b,c, a School of Mathematical Sciences, National Institute of Science Education and Research, Bhubaneswar,
More informationMixtures of multiple testing procedures for gatekeeping applications in clinical trials
Research Article Received 29 January 2010, Accepted 26 May 2010 Published online 18 April 2011 in Wiley Online Library (wileyonlinelibrary.com) DOI: 10.1002/sim.4008 Mixtures of multiple testing procedures
More informationarxiv: v2 [stat.me] 6 Sep 2013
Sequential Tests of Multiple Hypotheses Controlling Type I and II Familywise Error Rates arxiv:1304.6309v2 [stat.me] 6 Sep 2013 Jay Bartroff and Jinlin Song Department of Mathematics, University of Southern
More informationMULTISTAGE AND MIXTURE PARALLEL GATEKEEPING PROCEDURES IN CLINICAL TRIALS
Journal of Biopharmaceutical Statistics, 21: 726 747, 2011 Copyright Taylor & Francis Group, LLC ISSN: 1054-3406 print/1520-5711 online DOI: 10.1080/10543406.2011.551333 MULTISTAGE AND MIXTURE PARALLEL
More informationGroup sequential designs with negative binomial data
Group sequential designs with negative binomial data Ekkehard Glimm 1 Tobias Mütze 2,3 1 Statistical Methodology, Novartis, Basel, Switzerland 2 Department of Medical Statistics, University Medical Center
More informationEstimation in Flexible Adaptive Designs
Estimation in Flexible Adaptive Designs Werner Brannath Section of Medical Statistics Core Unit for Medical Statistics and Informatics Medical University of Vienna BBS and EFSPI Scientific Seminar on Adaptive
More informationOn the Inefficiency of the Adaptive Design for Monitoring Clinical Trials
On the Inefficiency of the Adaptive Design for Monitoring Clinical Trials Anastasios A. Tsiatis and Cyrus Mehta http://www.stat.ncsu.edu/ tsiatis/ Inefficiency of Adaptive Designs 1 OUTLINE OF TOPICS Hypothesis
More informationComparing Adaptive Designs and the. Classical Group Sequential Approach. to Clinical Trial Design
Comparing Adaptive Designs and the Classical Group Sequential Approach to Clinical Trial Design Christopher Jennison Department of Mathematical Sciences, University of Bath, UK http://people.bath.ac.uk/mascj
More informationCompatible simultaneous lower confidence bounds for the Holm procedure and other Bonferroni based closed tests
Compatible simultaneous lower confidence bounds for the Holm procedure and other Bonferroni based closed tests K. Strassburger 1, F. Bretz 2 1 Institute of Biometrics & Epidemiology German Diabetes Center,
More informationOverrunning in Clinical Trials: a Methodological Review
Overrunning in Clinical Trials: a Methodological Review Dario Gregori Unit of Biostatistics, Epidemiology and Public Health Department of Cardiac, Thoracic and Vascular Sciences dario.gregori@unipd.it
More informationPubh 8482: Sequential Analysis
Pubh 8482: Sequential Analysis Joseph S. Koopmeiners Division of Biostatistics University of Minnesota Week 10 Class Summary Last time... We began our discussion of adaptive clinical trials Specifically,
More informationTwo-Phase, Three-Stage Adaptive Designs in Clinical Trials
Japanese Journal of Biometrics Vol. 35, No. 2, 69 93 (2014) Preliminary Report Two-Phase, Three-Stage Adaptive Designs in Clinical Trials Hiroyuki Uesaka 1, Toshihiko Morikawa 2 and Akiko Kada 3 1 The
More informationSample Size and Power I: Binary Outcomes. James Ware, PhD Harvard School of Public Health Boston, MA
Sample Size and Power I: Binary Outcomes James Ware, PhD Harvard School of Public Health Boston, MA Sample Size and Power Principles: Sample size calculations are an essential part of study design Consider
More informationAdaptive clinical trials with subgroup selection
Adaptive clinical trials with subgroup selection Nigel Stallard 1, Tim Friede 2, Nick Parsons 1 1 Warwick Medical School, University of Warwick, Coventry, UK 2 University Medical Center Göttingen, Göttingen,
More informationPubh 8482: Sequential Analysis
Pubh 8482: Sequential Analysis Joseph S. Koopmeiners Division of Biostatistics University of Minnesota Week 12 Review So far... We have discussed the role of phase III clinical trials in drug development
More informationOn Generalized Fixed Sequence Procedures for Controlling the FWER
Research Article Received XXXX (www.interscience.wiley.com) DOI: 10.1002/sim.0000 On Generalized Fixed Sequence Procedures for Controlling the FWER Zhiying Qiu, a Wenge Guo b and Gavin Lynch c Testing
More informationCSE 312 Final Review: Section AA
CSE 312 TAs December 8, 2011 General Information General Information Comprehensive Midterm General Information Comprehensive Midterm Heavily weighted toward material after the midterm Pre-Midterm Material
More informationAdaptive Designs: Why, How and When?
Adaptive Designs: Why, How and When? Christopher Jennison Department of Mathematical Sciences, University of Bath, UK http://people.bath.ac.uk/mascj ISBS Conference Shanghai, July 2008 1 Adaptive designs:
More informationGroup Sequential Designs: Theory, Computation and Optimisation
Group Sequential Designs: Theory, Computation and Optimisation Christopher Jennison Department of Mathematical Sciences, University of Bath, UK http://people.bath.ac.uk/mascj 8th International Conference
More informationThe SEQDESIGN Procedure
SAS/STAT 9.2 User s Guide, Second Edition The SEQDESIGN Procedure (Book Excerpt) This document is an individual chapter from the SAS/STAT 9.2 User s Guide, Second Edition. The correct bibliographic citation
More informationAdaptive designs beyond p-value combination methods. Ekkehard Glimm, Novartis Pharma EAST user group meeting Basel, 31 May 2013
Adaptive designs beyond p-value combination methods Ekkehard Glimm, Novartis Pharma EAST user group meeting Basel, 31 May 2013 Outline Introduction Combination-p-value method and conditional error function
More informationMultiple Testing. Anjana Grandhi. BARDS, Merck Research Laboratories. Rahway, NJ Wenge Guo. Department of Mathematical Sciences
Control of Directional Errors in Fixed Sequence arxiv:1602.02345v2 [math.st] 18 Mar 2017 Multiple Testing Anjana Grandhi BARDS, Merck Research Laboratories Rahway, NJ 07065 Wenge Guo Department of Mathematical
More informationMonitoring clinical trial outcomes with delayed response: Incorporating pipeline data in group sequential and adaptive designs. Christopher Jennison
Monitoring clinical trial outcomes with delayed response: Incorporating pipeline data in group sequential and adaptive designs Christopher Jennison Department of Mathematical Sciences, University of Bath,
More informationAdaptive Treatment Selection with Survival Endpoints
Adaptive Treatment Selection with Survival Endpoints Gernot Wassmer Institut für Medizinische Statisti, Informati und Epidemiologie Universität zu Köln Joint wor with Marus Roters, Omnicare Clinical Research,
More informationPRINCIPLES OF OPTIMAL SEQUENTIAL PLANNING
C. Schmegner and M. Baron. Principles of optimal sequential planning. Sequential Analysis, 23(1), 11 32, 2004. Abraham Wald Memorial Issue PRINCIPLES OF OPTIMAL SEQUENTIAL PLANNING Claudia Schmegner 1
More informationProblems ( ) 1 exp. 2. n! e λ and
Problems The expressions for the probability mass function of the Poisson(λ) distribution, and the density function of the Normal distribution with mean µ and variance σ 2, may be useful: ( ) 1 exp. 2πσ
More informationMultistage Tests of Multiple Hypotheses
Communications in Statistics Theory and Methods, 39: 1597 167, 21 Copyright Taylor & Francis Group, LLC ISSN: 361-926 print/1532-415x online DOI: 1.18/3619282592852 Multistage Tests of Multiple Hypotheses
More informationSAS/STAT 15.1 User s Guide The SEQDESIGN Procedure
SAS/STAT 15.1 User s Guide The SEQDESIGN Procedure This document is an individual chapter from SAS/STAT 15.1 User s Guide. The correct bibliographic citation for this manual is as follows: SAS Institute
More informationAn Adaptive Futility Monitoring Method with Time-Varying Conditional Power Boundary
An Adaptive Futility Monitoring Method with Time-Varying Conditional Power Boundary Ying Zhang and William R. Clarke Department of Biostatistics, University of Iowa 200 Hawkins Dr. C-22 GH, Iowa City,
More informationGroup-Sequential Tests for One Proportion in a Fleming Design
Chapter 126 Group-Sequential Tests for One Proportion in a Fleming Design Introduction This procedure computes power and sample size for the single-arm group-sequential (multiple-stage) designs of Fleming
More informationAdaptive Extensions of a Two-Stage Group Sequential Procedure for Testing a Primary and a Secondary Endpoint (II): Sample Size Re-estimation
Research Article Received XXXX (www.interscience.wiley.com) DOI: 10.100/sim.0000 Adaptive Extensions of a Two-Stage Group Sequential Procedure for Testing a Primary and a Secondary Endpoint (II): Sample
More informationA Mixture Gatekeeping Procedure Based on the Hommel Test for Clinical Trial Applications
A Mixture Gatekeeping Procedure Based on the Hommel Test for Clinical Trial Applications Thomas Brechenmacher (Dainippon Sumitomo Pharma Co., Ltd.) Jane Xu (Sunovion Pharmaceuticals Inc.) Alex Dmitrienko
More informationSAMPLE SIZE RE-ESTIMATION FOR ADAPTIVE SEQUENTIAL DESIGN IN CLINICAL TRIALS
Journal of Biopharmaceutical Statistics, 18: 1184 1196, 2008 Copyright Taylor & Francis Group, LLC ISSN: 1054-3406 print/1520-5711 online DOI: 10.1080/10543400802369053 SAMPLE SIZE RE-ESTIMATION FOR ADAPTIVE
More informationA Type of Sample Size Planning for Mean Comparison in Clinical Trials
Journal of Data Science 13(2015), 115-126 A Type of Sample Size Planning for Mean Comparison in Clinical Trials Junfeng Liu 1 and Dipak K. Dey 2 1 GCE Solutions, Inc. 2 Department of Statistics, University
More informationSequential Analysis of Quality of Life Measurements Using Mixed Rasch Models
1 Sequential Analysis of Quality of Life Measurements Using Mixed Rasch Models Véronique Sébille 1, Jean-Benoit Hardouin 1 and Mounir Mesbah 2 1. Laboratoire de Biostatistique, Faculté de Pharmacie, Université
More informationHochberg Multiple Test Procedure Under Negative Dependence
Hochberg Multiple Test Procedure Under Negative Dependence Ajit C. Tamhane Northwestern University Joint work with Jiangtao Gou (Northwestern University) IMPACT Symposium, Cary (NC), November 20, 2014
More informationStatistica Sinica Preprint No: SS R1
Statistica Sinica Preprint No: SS-2017-0072.R1 Title Control of Directional Errors in Fixed Sequence Multiple Testing Manuscript ID SS-2017-0072.R1 URL http://www.stat.sinica.edu.tw/statistica/ DOI 10.5705/ss.202017.0072
More informationFinding Critical Values with Prefixed Early. Stopping Boundaries and Controlled Type I. Error for A Two-Stage Adaptive Design
Finding Critical Values with Prefixed Early Stopping Boundaries and Controlled Type I Error for A Two-Stage Adaptive Design Jingjing Chen 1, Sanat K. Sarkar 2, and Frank Bretz 3 September 27, 2009 1 ClinForce-GSK
More informationSequential Plans and Risk Evaluation
C. Schmegner and M. Baron. Sequential Plans and Risk Evaluation. Sequential Analysis, 26(4), 335 354, 2007. Sequential Plans and Risk Evaluation Claudia Schmegner Department of Mathematical Sciences, DePaul
More information40.530: Statistics. Professor Chen Zehua. Singapore University of Design and Technology
Singapore University of Design and Technology Lecture 9: Hypothesis testing, uniformly most powerful tests. The Neyman-Pearson framework Let P be the family of distributions of concern. The Neyman-Pearson
More informationIndependent Increments in Group Sequential Tests: A Review
Independent Increments in Group Sequential Tests: A Review KyungMann Kim kmkim@biostat.wisc.edu University of Wisconsin-Madison, Madison, WI, USA July 13, 2013 Outline Early Sequential Analysis Independent
More informationGroup Sequential Methods. for Clinical Trials. Christopher Jennison, Dept of Mathematical Sciences, University of Bath, UK
Group Sequential Methods for Clinical Trials Christopher Jennison, Dept of Mathematical Sciences, University of Bath, UK http://www.bath.ac.uk/οmascj PSI, London, 22 October 2003 1 Plan of talk 1. Why
More informationAdaptive Methods for Clinical Trials Applications
Adaptive Methods for Clinical Trials Applications Part I: Overview of Literature and a New Approach Tze Leung Lai Department of Statistics, Stanford University October 18, 2011 Tze Leung Lai (NY) Group
More informationINTRODUCTION TO INTERSECTION-UNION TESTS
INTRODUCTION TO INTERSECTION-UNION TESTS Jimmy A. Doi, Cal Poly State University San Luis Obispo Department of Statistics (jdoi@calpoly.edu Key Words: Intersection-Union Tests; Multiple Comparisons; Acceptance
More informationclinical trials Abstract Multi-arm multi-stage (MAMS) trials can improve the efficiency of the drug
A multi-stage drop-the-losers design for multi-arm clinical trials James Wason 1, Nigel Stallard 2, Jack Bowden 1, and Christopher Jennison 3 1 MRC Biostatistics Unit, Cambridge 2 Warwick Medical School,
More informationDesigning multi-arm multi-stage clinical trials using a risk-benefit criterion for treatment selection
Research Article Statistics Received XXXX (www.interscience.wiley.com) DOI: 10.1002/sim.0000 Designing multi-arm multi-stage clinical trials using a risk-benefit criterion for treatment selection Thomas
More informationPubh 8482: Sequential Analysis
Pubh 8482: Sequential Analysis Joseph S. Koopmeiners Division of Biostatistics University of Minnesota Week 7 Course Summary To this point, we have discussed group sequential testing focusing on Maintaining
More informationHypothesis Test. The opposite of the null hypothesis, called an alternative hypothesis, becomes
Neyman-Pearson paradigm. Suppose that a researcher is interested in whether the new drug works. The process of determining whether the outcome of the experiment points to yes or no is called hypothesis
More informationOptimal group sequential designs for simultaneous testing of superiority and non-inferiority
Optimal group sequential designs for simultaneous testing of superiority and non-inferiority Fredrik Öhrn AstraZeneca R & D Mölndal, SE-431 83 Mölndal, Sweden and Christopher Jennison Department of Mathematical
More informationDivision of Pharmacoepidemiology And Pharmacoeconomics Technical Report Series
Division of Pharmacoepidemiology And Pharmacoeconomics Technical Report Series Year: 2013 #006 The Expected Value of Information in Prospective Drug Safety Monitoring Jessica M. Franklin a, Amanda R. Patrick
More informationOn Procedures Controlling the FDR for Testing Hierarchically Ordered Hypotheses
On Procedures Controlling the FDR for Testing Hierarchically Ordered Hypotheses Gavin Lynch Catchpoint Systems, Inc., 228 Park Ave S 28080 New York, NY 10003, U.S.A. Wenge Guo Department of Mathematical
More informationSample size re-estimation in clinical trials. Dealing with those unknowns. Chris Jennison. University of Kyoto, January 2018
Sample Size Re-estimation in Clinical Trials: Dealing with those unknowns Christopher Jennison Department of Mathematical Sciences, University of Bath, UK http://people.bath.ac.uk/mascj University of Kyoto,
More informationGroup sequential designs for negative binomial outcomes
Group sequential designs for negative binomial outcomes Tobias Mütze a, Ekkehard Glimm b,c, Heinz Schmidli b, and Tim Friede a,d a Department of Medical Statistics, University Medical Center Göttingen,
More informationsimple if it completely specifies the density of x
3. Hypothesis Testing Pure significance tests Data x = (x 1,..., x n ) from f(x, θ) Hypothesis H 0 : restricts f(x, θ) Are the data consistent with H 0? H 0 is called the null hypothesis simple if it completely
More informationGroup Sequential Methods. for Clinical Trials. Christopher Jennison, Dept of Mathematical Sciences, University of Bath, UK
Group Sequential Methods for Clinical Trials Christopher Jennison, Dept of Mathematical Sciences, University of Bath, UK http://wwwbathacuk/ mascj University of Malaysia, Kuala Lumpur March 2004 1 Plan
More informationSequential Procedure for Testing Hypothesis about Mean of Latent Gaussian Process
Applied Mathematical Sciences, Vol. 4, 2010, no. 62, 3083-3093 Sequential Procedure for Testing Hypothesis about Mean of Latent Gaussian Process Julia Bondarenko Helmut-Schmidt University Hamburg University
More informationBios 6649: Clinical Trials - Statistical Design and Monitoring
Bios 6649: Clinical Trials - Statistical Design and Monitoring Spring Semester 2015 John M. Kittelson Department of Biostatistics & Informatics Colorado School of Public Health University of Colorado Denver
More informationBonferroni - based gatekeeping procedure with retesting option
Bonferroni - based gatekeeping procedure with retesting option Zhiying Qiu Biostatistics and Programming, Sanofi Bridgewater, NJ 08807, U.S.A. Wenge Guo Department of Mathematical Sciences New Jersey Institute
More informationThe International Journal of Biostatistics
The International Journal of Biostatistics Volume 7, Issue 1 2011 Article 12 Consonance and the Closure Method in Multiple Testing Joseph P. Romano, Stanford University Azeem Shaikh, University of Chicago
More informationCitation for final published version: Publishers page:
This is an Open Access document downloaded from ORCA, Cardiff University's institutional repository: http://orca.cf.ac.uk/110115/ This is the author s version of a work that was submitted to / accepted
More informationInterim Monitoring of. Clinical Trials. Christopher Jennison, Dept of Mathematical Sciences, University of Bath, UK
Interim Monitoring of Clinical Trials Christopher Jennison, Dept of Mathematical Sciences, University of Bath, UK http://www.bath.ac.uk/οmascj Magdeburg, 1 October 2003 1 Plan of talk 1. Why sequential
More informationIEOR165 Discussion Week 12
IEOR165 Discussion Week 12 Sheng Liu University of California, Berkeley Apr 15, 2016 Outline 1 Type I errors & Type II errors 2 Multiple Testing 3 ANOVA IEOR165 Discussion Sheng Liu 2 Type I errors & Type
More informationSample Size Determination
Sample Size Determination 018 The number of subjects in a clinical study should always be large enough to provide a reliable answer to the question(s addressed. The sample size is usually determined by
More informationSequential Testing in Reliability and Validity Studies With Repeated Measurements per Subject
http://ijsp.ccsenet.org International Journal of Statistics and Probability Vol. 8, No. 1; 019 Sequential Testing in Reliability and Validity Studies With Repeated Measurements per Subject Steven B. Kim
More informationIntroductory Econometrics
Session 4 - Testing hypotheses Roland Sciences Po July 2011 Motivation After estimation, delivering information involves testing hypotheses Did this drug had any effect on the survival rate? Is this drug
More informationTesting a Primary and a Secondary Endpoint in a Confirmatory Group Sequential Clinical Trial
Testing a Primary and a Secondary Endpoint in a Confirmatory Group Sequential Clinical Trial ExL Pharma Workshop 2010 Rockville, MD Cyrus R. Mehta President, Cytel Corporation January 26, 2010 email: mehta@cytel.com
More informationFamilywise Error Rate Controlling Procedures for Discrete Data
Familywise Error Rate Controlling Procedures for Discrete Data arxiv:1711.08147v1 [stat.me] 22 Nov 2017 Yalin Zhu Center for Mathematical Sciences, Merck & Co., Inc., West Point, PA, U.S.A. Wenge Guo Department
More informationGroup Sequential Tests for Delayed Responses
Group Sequential Tests for Delayed Responses Lisa Hampson Department of Mathematics and Statistics, Lancaster University, UK Chris Jennison Department of Mathematical Sciences, University of Bath, UK Read
More informationStatistical Aspects of Futility Analyses. Kevin J Carroll. nd 2013
Statistical Aspects of Futility Analyses Kevin J Carroll March Spring 222013 nd 2013 1 Contents Introduction The Problem in Statistical Terms Defining Futility Three Common Futility Rules The Maths An
More informationc Copyright 2014 Navneet R. Hakhu
c Copyright 04 Navneet R. Hakhu Unconditional Exact Tests for Binomial Proportions in the Group Sequential Setting Navneet R. Hakhu A thesis submitted in partial fulfillment of the requirements for the
More informationSequential/Adaptive Benchmarking
Sequential/Adaptive Benchmarking Manuel J. A. Eugster Institut für Statistik Ludwig-Maximiliams-Universität München Validation in Statistics and Machine Learning, 2010 1 / 22 Benchmark experiments Data
More informationAn Alpha-Exhaustive Multiple Testing Procedure
Current Research in Biostatistics Original Research Paper An Alpha-Exhaustive Multiple Testing Procedure, Mar Chang, Xuan Deng and John Balser Boston University, Boston MA, USA Veristat, Southborough MA,
More informationMultiple Endpoints: A Review and New. Developments. Ajit C. Tamhane. (Joint work with Brent R. Logan) Department of IE/MS and Statistics
1 Multiple Endpoints: A Review and New Developments Ajit C. Tamhane (Joint work with Brent R. Logan) Department of IE/MS and Statistics Northwestern University Evanston, IL 60208 ajit@iems.northwestern.edu
More informationClinical Trial Design Using A Stopped Negative Binomial Distribution. Michelle DeVeaux and Michael J. Kane and Daniel Zelterman
Statistics and Its Interface Volume 0 (0000) 1 10 Clinical Trial Design Using A Stopped Negative Binomial Distribution Michelle DeVeaux and Michael J. Kane and Daniel Zelterman arxiv:1508.01264v8 [math.st]
More informationApplying the Benjamini Hochberg procedure to a set of generalized p-values
U.U.D.M. Report 20:22 Applying the Benjamini Hochberg procedure to a set of generalized p-values Fredrik Jonsson Department of Mathematics Uppsala University Applying the Benjamini Hochberg procedure
More informationThe Limb-Leaf Design:
The Limb-Leaf Design: A New Way to Explore the Dose Response Curve in Adaptive Seamless Phase II/III Trials John Spivack Submitted in partial fulfillment of the Requirements for the degree of Doctor of
More informationOn weighted Hochberg procedures
Biometrika (2008), 95, 2,pp. 279 294 C 2008 Biometrika Trust Printed in Great Britain doi: 10.1093/biomet/asn018 On weighted Hochberg procedures BY AJIT C. TAMHANE Department of Industrial Engineering
More informationA Gatekeeping Test on a Primary and a Secondary Endpoint in a Group Sequential Design with Multiple Interim Looks
A Gatekeeping Test in a Group Sequential Design 1 A Gatekeeping Test on a Primary and a Secondary Endpoint in a Group Sequential Design with Multiple Interim Looks Ajit C. Tamhane Department of Industrial
More informationStatistics Ph.D. Qualifying Exam: Part I October 18, 2003
Statistics Ph.D. Qualifying Exam: Part I October 18, 2003 Student Name: 1. Answer 8 out of 12 problems. Mark the problems you selected in the following table. 1 2 3 4 5 6 7 8 9 10 11 12 2. Write your answer
More informationADAPTIVE SEAMLESS DESIGNS: SELECTION AND PROSPECTIVE TESTING OF HYPOTHESES
ADAPTIVE SEAMLESS DESIGNS: SELECTION AND PROSPECTIVE TESTING OF HYPOTHESES Christopher Jennison Department of Mathematical Sciences, University of Bath, Bath BA2 7AY, U. K. email: cj@maths.bath.ac.uk and
More informationSample Size Estimation for Studies of High-Dimensional Data
Sample Size Estimation for Studies of High-Dimensional Data James J. Chen, Ph.D. National Center for Toxicological Research Food and Drug Administration June 3, 2009 China Medical University Taichung,
More informationAdaptive Dunnett Tests for Treatment Selection
s for Treatment Selection Franz König 1 Werner Brannath 1 Frank Bretz 2 Martin Posch 1 1 Section of Medical Statistics Medical University of Vienna 2 Novartis Pharma AG Basel Workshop Adaptive Designs
More information